The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


STRIASCAN



CIS bio InternationalEU/1/19/1372/001-002

Main Information

Trade NameSTRIASCAN
Active SubstancesIOFLUPANE (1231)
Dosage FormSolution for injection
Licence HolderCIS bio International
Licence NumberEU/1/19/1372/001-002

Group Information

ATC CodeV09AB Iodine (123I) compounds
V09AB03 iodine ioflupane (123I)

Status

License statusAuthorised
Licence Issued25/06/2019
Legal statusProduct subject to Restricted Prescription (C)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back